Related Experiment Video
Updated: Mar 9, 2026
15:29
Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
8.7K
Neurobrucellosis: Unexpected Answer From Metagenomic Next-Generation Sequencing
Kanokporn Mongkolrattanothai1, Samia N Naccache2,3,4, Jeffrey M Bender1
1Department of Pediatrics, Division of Infectious Diseases.
Journal of the Pediatric Infectious Diseases Society
|January 8, 2017
Summary
Diagnosing brucellosis is challenging due to unreliable standard tests. Metagenomic next-generation sequencing successfully identified neurobrucellosis in cerebrospinal fluid, enabling effective treatment and recovery.
Area of Science:
- Neurology
- Infectious Diseases
- Genomics
Background:
- Brucellosis diagnosis is often complicated by the limitations of conventional culture and serological techniques, which show inconsistent sensitivity and specificity.
- Neurobrucellosis, a serious complication, presents diagnostic challenges due to its variable clinical manifestations and difficulties in pathogen detection.
Purpose of the Study:
- To evaluate the utility of a metagenomic next-generation sequencing (mNGS) assay for the diagnosis of neurobrucellosis.
- To demonstrate the application of mNGS in a clinical setting for identifying a rare infectious agent in cerebrospinal fluid.
Main Methods:
- Cerebrospinal fluid (CSF) sample analysis using a metagenomic next-generation sequencing (mNGS) assay.
- Comparison of mNGS results with conventional diagnostic methods (implicitly, given the background).
Main Results:
- The mNGS assay successfully identified the causative agent of brucellosis in the cerebrospinal fluid sample.
- This molecular diagnosis facilitated the initiation of targeted antibiotic therapy.
Conclusions:
- Metagenomic next-generation sequencing offers a sensitive and specific approach for diagnosing neurobrucellosis, overcoming limitations of traditional methods.
- The use of mNGS in clinical practice can lead to timely diagnosis, appropriate treatment, and improved patient outcomes in complex infectious cases.
Related Concept Videos
03:00Next-generation Sequencing
100.0K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
100.0K
01:29Modern Molecular Taxonomy
804
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
804
02:59Animal Mitochondrial Genetics
9.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.8K